The Hartmann Lab in collaboration with CCS colleagues Richard Greil, Alexander Egle, Fritz Aberger and Daniel Neureiter published new data on the role of Integrin-Linked Kinase in Chronic Lymphocytic Leukemia (CLL). The findings identify a critical role of ILK in CLL development in response to TNFa-NFkB signaling. The study has been published on Feb 2 2016 in Cancer Research ahead of print. For details see Krenn et al., 2016. Cancer Res.